Publikationen, an denen er mitarbeitet Olga Laosa Zafra (6)

2021

  1. Impact of in-hospital discontinuation with angiotensin receptor blockers or converting enzyme inhibitors on mortality of COVID-19 patients: a retrospective cohort study

    BMC Medicine, Vol. 19, Núm. 1

2020

  1. Use of renin–angiotensin–aldosterone system inhibitors and risk of COVID-19 requiring admission to hospital: a case-population study

    The Lancet, Vol. 395, Núm. 10238, pp. 1705-1714

2017

  1. Cyclosporine Use in Epidermal Necrolysis Is Associated with an Important Mortality Reduction: Evidence from Three Different Approaches

    Journal of Investigative Dermatology, Vol. 137, Núm. 10, pp. 2092-2100

  2. Ensayo clínico aleatorizado para evaluar la efectividad de un programa de intervención multimodal en pacientes diabéticos tipo 2 prefrágiles y frágiles sobre la fragilidad y la calidad de vida: MIDFRAIL. Análisis interino

    Ensayo clínico aleatorizado para evaluar la efectividad de un programa de intervención multimodal en pacientes diabéticos tipo 2 prefrágiles y frágiles sobre la fragilidad y la calidad de vida: MIDFRAIL. Análisis interino

  3. Significant HLA class I type associations with aromatic antiepileptic drug (AED)-induced SJS/TEN are different from those found for the same AED-induced DRESS in the Spanish population

    Pharmacological Research, Vol. 115, pp. 168-178

2016

  1. The HLA-B∗15:02 allele in a Spanish Romani patient with carbamazepine-induced Stevens-Johnson syndrome

    Pharmacogenomics, Vol. 17, Núm. 6, pp. 541-545